Caspase
Caspase - Proteases - Signaling Pathways | GlpBio
Read More about this categoryShow Less
Caspases (cysteine-dependent aspartate specific ptotease) are a family of cysteine proteases that play an essential role in cell apoptosis. Caspases contain a conserved QACXG pentapeptide active site motif and are characterized by specificity for aspartic acid in the P1 position. The synthesis of caspases involves the activation of inactive proenzymes, which contain an N-terminal peptide (prodomain) together with two subunits (one small and one large), following cleavage at specific aspartate cleavage sites. Caspases can be classified into three subfamilies, due to phylogenetic analysis, including an ICE subfamily (caspases-1, -4 and -5), a CED-3/CPP32 subfamily (caspases-3, -6, -7, -8, -9 and -10) and an ICH-1/Nedd2 subfamily (caspase-2).
Products Related to Caspase(168)
- GC78952d-(KLAKLAK)2, Proapoptotic Peptide acetatePurity: >98.00%
d-(KLAKLAK) 2, Proapoptotic Peptide acetate is a pro- Apoptotic peptide whose core mechanism of action is to disrupt organelle membranes, especially mitochondrial membranes, thereby inducing apoptosis.
- GC78957(2S,3R,4S)-ASX-173CAS: 2748800-07-7Purity: >99.00%
(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173.
- GC79004PMV6-PEG4-BI2536Purity: >98.00%
PMV6-PEG4-BI2536 is an RIPTAC-like bifunctional molecule that promotes the formation of the p53 Y 220C -PLK1 ternary complex ( EC 50 = 1.4 μM).
- GC79103Berzosertib hydrochlorideCAS: 1428935-04-9Purity: >98.50%
Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor.
- GC79475MKK7-JNK activator 1CAS: 3100092-62-1Purity: >99.50%
MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator.
- GC79577PFKFB4-IN-1CAS: 2664831-55-2Purity: >99.50%
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels.
- GC79807RP-182 acetatePurity: >98.50%
RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 ( K d = 8 μM) on the surface of tumor-associated macrophages (TAMs).
- GC79871CHNQD-00824CAS: 2222643-74-3Purity: >98%
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect.
- GC80886PROTAC CDK2/4/6 Degrader-2CAS: 2541626-49-5Purity: >97.00%
PROTAC CDK2/4/6 Degrader-2 is a CDK2/4/6 PROTAC degrader.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC78952 | d-(KLAKLAK)2, Proapoptotic Peptide acetate | - | >98.00% | |
d-(KLAKLAK) 2, Proapoptotic Peptide acetate is a pro- Apoptotic peptide whose core mechanism of action is to disrupt organelle membranes, especially mitochondrial membranes, thereby inducing apoptosis. | ||||
| GC78953 | Haplophytin-A | 366477-44-3 | >98.00% | |
Haplophytin-A is a quinoline alkaloid. | ||||
| GC78954 | OH14 | 1018153-87-1 | >99.50% | |
OH14 is a cellular FLICE-like inhibitory protein ( cFLIP) inhibitor and TNF-related apoptosis-inducing ligand ( TRAIL ) sensitizer. | ||||
| GC78957 | (2S,3R,4S)-ASX-173 | 2748800-07-7 | >99.00% | |
(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173. | ||||
| GC78958 | TMLB-C16 | 2923531-50-2 | >99.00% | |
TMLB-C16 is a potent and orally active B3GAT3 inhibitor with a K D of 3.962 μM. | ||||
| GC78961 | GPS167 | 3034312-19-8 | >98% | |
GPS167 is a CLK kinase inhibitor that potently and selectively inhibits recombinant human CLK1, CLK2 and CLK4. | ||||
| GC78962 | MS1129 | - | >98% | |
MS1129 is a DNMT degrader that induces proteasomal degradation of DNMT1, DNMT3A and DNMT3B proteins. | ||||
| GC79004 | PMV6-PEG4-BI2536 | - | >98.00% | |
PMV6-PEG4-BI2536 is an RIPTAC-like bifunctional molecule that promotes the formation of the p53 Y 220C -PLK1 ternary complex ( EC 50 = 1.4 μM). | ||||
| GC79072 | MS6076 | - | >98% | |
MS6076 is a mitochondrial protease ClpP agonist. | ||||
| GC79103 | Berzosertib hydrochloride | 1428935-04-9 | >98.50% | |
Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. | ||||
| GC79111 | CK2-TN03 | 313226-24-3 | >98.00% | |
CK2-TN03 is an ATP-competitive casein kinase 2 ( CK2 ) inhibitor, with an IC 50 of 165 nM and a K i of 20 nM. | ||||
| GC79144 | MC3817 free base | - | >98% | |
MC3817 free base is a selective DNMT1 inhibitor. | ||||
| GC79145 | MC3817 | - | >99.50% | |
MC3817 is a selective DNMT1 inhibitor. | ||||
| GC79147 | HLC40 | - | >99.50% | |
HLC40 is a MLL1 histone methyltransferase inhibitor with an IC 50 of 0.82 μM by binding to WDR5. | ||||
| GC79337 | ZSTK3744 | - | >98.00% | |
ZSTK3744 is an aryl hydrocarbon receptor ( AhR ) agonist. | ||||
| GC79451 | JP-11646 | 1902983-63-4 | >98.50% | |
JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM). | ||||
| GC79475 | MKK7-JNK activator 1 | 3100092-62-1 | >99.50% | |
MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator. | ||||
| GC79577 | PFKFB4-IN-1 | 2664831-55-2 | >99.50% | |
PFKFB4-IN-1 is a potent and selective ATP-competitive PFKFB4 inhibitor ( IC 50 = 4.50 μM) that reduces intracellular PFKFB4 protein levels. | ||||
| GC79806 | TKL002 | 3098518-95-4 | >98.00% | |
TKL002 is a blood-brain barrier-permeable inhibitor of the CTH/H 2 S/NF-κB/EMT signaling axis. | ||||
| GC79807 | RP-182 acetate | - | >98.50% | |
RP-182 acetate is a synthetic immunomodulatory peptide that exerts anti-tumor effects by targeting the mannose receptor CD206 ( K d = 8 μM) on the surface of tumor-associated macrophages (TAMs). | ||||
| GC79871 | CHNQD-00824 | 2222643-74-3 | >98% | |
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect. | ||||
| GC80880 | dCASP1-55 | - | >98% | |
dCASP1-55 is a cereblon-dependent caspase-1 ( CASP1 ) PROTAC degrader. | ||||
| GC80886 | PROTAC CDK2/4/6 Degrader-2 | 2541626-49-5 | >97.00% | |
PROTAC CDK2/4/6 Degrader-2 is a CDK2/4/6 PROTAC degrader. | ||||
| GC80887 | MA203 | - | >98% | |
MA203 is a selective CHK1 PROTAC degrader. | ||||
